This congress is a platform for discussing recent advances in
understanding the pathophysiology of lung cancer. It will enhance
multidisciplinary collaboration between various specialties involved in
the care of lung cancer patients.
At the end of conference attendees will be able to do the following upon completion of this activity:
- Provide a multidisciplinary (MDT) approach to patients with lung cancer that involves the pathologists, pulmunologist, thoracic surgeon as well as Medical Oncologist; MDT is the new standards of approach and this conference aims on showing the benefit of this approach.
- Discuss recent advances in lung cancer therapy for both Non small cell lung cancer and small cell lung cancer.
- Better undertsand recent therapies mechanism of action and toxicities in new treatment modalities such immunotherapy.
This congress targets medical oncologists, radiation oncologists,
surgeons, radiologists, pathologists, pulmonologists, residents,
fellows, nurses and medical students.